GlassScriptPhysician profile
Jaydeen M Morris
NPI 1972079382
$8,809.25
in general payments reported to CMS, 2019-2025
38 companies · $1,917 in 2025
The $1,917 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,507 · 2022: $1,377 · 2023: $1,948 · 2024: $2,060 · 2025: $1,917.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,925.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,924.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,849.05 | 2021-2025 | Repatha, Otezla, Evenity |
| Abbvie INC. | $1,607.13 | 2021-2025 | |
| Novo Nordisk INC | $928.33 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $908.69 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $550.58 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $541.73 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $462.29 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $246.77 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Genzyme Corporation | $155.88 | 2022-2025 | |
| Exact Sciences Corporation | $143.07 | 2023-2024 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $133.08 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.80 | 2022-2025 | Jardiance, Synjardy |
| Biohaven Pharmaceuticals, INC. | $120.42 | 2021 | |
| Novartis Pharmaceuticals Corporation | $109.30 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $103.42 | 2021-2025 | Trintellix |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaydeen Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.